The influence of ligands on the spin state of a metal ion is of central importance for bioinorganic chemistry, and the production of base‐metal catalysts for synthesis applications. Complexes derived from [Fe(bpp)2]2+ (bpp=2,6‐di{pyrazol‐1‐yl}pyridine) can be high‐spin, low‐spin, or spin‐crossover (SCO) active depending on the ligand substituents. Plots of the SCO midpoint temperature (T
1/2
) in solution vs. the relevant Hammett parameter show that the low‐spin state of the complex is stabilized by electron‐withdrawing pyridyl (“X”) substituents, but also by electron‐donating pyrazolyl (“Y”) substituents. Moreover, when a subset of complexes with halogeno X or Y substituents is considered, the two sets of compounds instead show identical trends of a small reduction in T
1/2
for increasing substituent electronegativity. DFT calculations reproduce these disparate trends, which arise from competing influences of pyridyl and pyrazolyl ligand substituents on Fe‐L σ and π bonding.
The temperature of spin-crossover in [Fe(3-bpp)(2)][BF(4)](2) (3-bpp = 2,6-di{pyrazol-3-yl}pyridine) tends to increase in associating solvents. In particular, T(½) shifts to 60-70 K higher temperature in water compared to organic solvents.
Wounds represent a significant cause of morbidity in the general population.A systematic focus is necessary on effective and timely diagnosis, on ensuring treatment is appropriate to the cause and condition of the wound and on active measures to prevent complications.A number of initiatives have commenced in order to provide a effective and efficient wound care.
. Solid (R)-3·MeNO 2 exhibits an unusualv ery gradual, but discontinuoust hermals pin-crossover with an approximate T1 = 2 of 350 K. The discontinuity around 240 Kl ies well below T1 = 2 , and is unconnected to ac rystallographic phase change occurring at 170 K. Rather,i tc an be correlated with ag radual ordering of the ligand conformation as the temperature is raised. The other solid compounds either exhibit spin-cross-
We report the syntheses of six new salts of the iron(III) complexes of four hexadentate Schiff bases of the saltrien-type derived from 1,8-diamino-3,6-diazaoctane and 2 equiv. of the appropriate salicylaldehyde derivative. Three of these new compounds undergo gradual spin-transitions centred between 155-204 K in the solid state, that proceed to 35-50% completeness. One of the other compounds remains high-spin on cooling, another is low-spin, while the last undergoes spin-crossover centred above room temperature. This spin-state variability is typical of solid compounds of this type. As an aid to understanding this behaviour, the crystal structures and magnetochemistry of the known spin-crossover salts [Fe(saltrien)]PF6, [Fe(saltrien)]ClO4 and [Fe(saltrien)]BPh4 have also been reexamined. The structural chemistry of all three salts was found to differ significantly from what has been previously reported. Correlation of the crystal structures and magnetic behaviour of the compounds in this and previous work suggests that the disposition of the two ligand phenoxy groups plays an important role in determining whether high-spin [Fe(saltrien)]+ complexes can undergo thermal spin-transitions.
ReuseUnless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version -refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher's website.
TakedownIf you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request.
ABSTRACTReaction of 2,6-difluoropyridine with 2 equiv indazole and NaH at room temperature affords a mixture of 2,6-bis(indazol-1-yl)pyridine (1-bip), 2-(indazol-1-yl)-6-(indazol-2-yl)pyridine (1,2-bip) and 2,6-bis(indazol-2-yl)pyridine (2-bip), which can be separated by solvent extraction. A two-step procedure using the same conditions also affords both 2-(indazol-1-yl)-6-(pyrazol-1-yl)pyridine (1-ipp) and 2-(indazol-1-yl)-6-(pyrazol-2-yl)pyridine (2-ipp). These are all annelated analogues of 2,6-di(pyrazol-1-yl)pyridine, an important ligand for spin-crossover complexes.Iron (
Reaction of CuF2 with one equivalent of 3{5}-(pyrid-2-yl)-5{3}-(tertbutyl)pyrazole (HL) and excess NH4OH in MeOH affords crystalline [NH4{Cu(micro-F)(microL)}6(CH2Cl2)2]HF2 in moderate yield. This compound contains the 12-MC-6 metallacrown [{Cu(micro-F)(micro-L)}6] (1) with a NH4 + ion at its center, and CH2Cl2 molecules complexed in bowl-shaped cavities above and below the Cu6F6 ring. Similar reactions using the bases MeNH2, glycine, l-alanine or beta-alanine afforded solvated crystals of [1(H3NMe)2]Cl2, [1(gly)2], [1(l-ala)2], and [1(beta-ala)2], respectively. The metallacrown 1 in these products contains methylammonium and zwitterionic amino-acid guests in its two bowl-shaped cavities; each of the amino acids hydrogen-bonds to three F atoms. A related reaction using 1,6-diaminohexane resulted in fixation of CO2 from the air to give solvated [1(H3NC6H12NHCO2)2], again with a zwitterionic guest. NMR, ESI-MS and UV/vis measurements suggest that the metallacrown 1 retains its integrity in several organic solvents, although it is unclear to what extent guest binding takes place in solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.